Project Details

Description

The impact of using AI in breast cancer screening will be evaluated in a randomized controlled trial with 100,000 participants (clinicaltrials.gov NCT04838756) to answer questions on clinical safety, efficacy and accuracy. The multidisciplinary research team will further evaluate the effect on healthcare resources and cost-effectiveness together with the ethical, legal and social implications of integrating AI in breast cancer screening.
AcronymMASAI
StatusActive
Effective start/end date2021/04/122025/12/31

Funding

  • Cancerfonden